Dare Bioscience DARE
NASDAQ DARE
$0.68 -0.01 (-1.26%)
As of: Oct 21, 2026 · 3:49 PM EDT

Dare Bioscience (DARE) Change in Receivables (2013 - 2024)

Updated

Dare Bioscience (DARE) posted Change in Receivables of $12,053 for FY2025.

Analysis

Dare Bioscience (DARE) Change in Receivables (2013 - 2024) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Receivables (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn -
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 1.35 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 1.37 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn -
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn -
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 1.09 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 333.00 Mn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -
10 Dare Bioscience 10.13 Mn -55.33 Mn -132,343.00 -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2024 -39,665.00
Mar 31, 2024 67,644.00
Mar 31, 2017 316,000.00
Mar 31, 2016 18,000.00
Dec 31, 2014 -250,000.00
Sep 30, 2014 789,000.00
Jun 30, 2014 -845,000.00
Mar 31, 2014 1.02 Mn
Dec 31, 2013 255,000.00
Sep 30, 2013 -111,000.00
Jun 30, 2013 246,000.00
Mar 31, 2013 -161,000.00
API Access

Dare Bioscience Change in Receivables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-receivables&ticker=DARE&period=max&api_key=YOUR_API_KEY